Experiential Pharmacogenomic Education for Providers


About this study

The aim of this study is to better understand providers’ attitudes, perceptions and knowledge of pharmacogenomics and to examine the impact of experiential education with providers.  

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

Inclusion Criteria:

  • 100 prescribers and pharmacists participating in the Center for Individualized Medicine pharmacogenomic testing pilot studies

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Timothy Curry, M.D., Ph.D.

Open for enrollment

Contact information:

Center for Individualized Medicine


More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer